Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Irritable Bowel Syndrome
NCT00977197Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregabalin in irritable bowel syndrome (IBS), sponsored by Mayo Clinic. Started Mar 2010; status: completed.
02
Drugs
pregabalin
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00977197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00977197.